Cyclic glycine-proline normalizes systolic blood pressure in high-fat diet-induced obese male rats

Nutrition, Metabolism and Cardiovascular Diseases - Tập 30 - Trang 339-346 - 2020
Fengxia Li1,2,3,4,5, Karen Liu4,5,6, Clint Gray7, Paul Harris8, Clare M. Reynolds7, Mark H. Vickers7, Jian Guan4,5,6
1The Seventh Affiliated Hospital, Sun Yat-sen University, 628 Zhenyuan Road, Guangming District, Shenzhen, 518107, China
2Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, 12 Jichang Road, Baiyun District, Guangzhou, 510000, China
3Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, Guangzhou Higher Education Mega Center, 280 Waihuangdong Road, Guangzhou, 510008, China
4The Department of Pharmacology and Clinical Pharmacology, School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland, 1142, New Zealand
5Centre for Brain Research, School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland, 1142, New Zealand
6Brain Research New Zealand, A Centre of Research Excellence, New Zealand
7The Liggins Institute, University of Auckland, 85 Park Road, Grafton, Auckland, 1142, New Zealand
8Department of Medicinal Chemistry, School of Chemistry, Faculty of Science, University of Auckland, 1142, New Zealand

Tài liệu tham khảo

Xu, 2016, Pediatric obesity: causes, symptoms, prevention and treatment, Exp Ther Med, 11, 15, 10.3892/etm.2015.2853 Brady, 2017, Obesity-related hypertension in children, Front Pediatr, 5, 197, 10.3389/fped.2017.00197 Clemmons, 2012, Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes, Endocrinol Metab Clin N Am, 41, 425, 10.1016/j.ecl.2012.04.017 Møller, 2009, Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects, Endocr Rev, 30, 152, 10.1210/er.2008-0027 Bodart, 2015, Somatotrope GHRH/GH/IGF-1 axis at the crossroads between immunosenescence and frailty, Ann N Y Acad Sci, 1351, 61, 10.1111/nyas.12857 Duan, 2005, Roles of insulin-like growth factor (IGF) binding proteins in regulating IGF actions, Gen Comp Endocrinol, 142, 44, 10.1016/j.ygcen.2004.12.022 Fan, 2019, Plasma cyclic glycine proline/IGF-1 ratio predicts clinical outcome and recovery in stroke patients, Ann Clin Trans Neurol, 2 Guan, 2018, The role for cyclic Glycine-Proline, a biological regulator of insulin-like growth factor-1 in pregnancy-related obesity and weight changes, J Biol Regul Homeost Agents, 32, 465 Singh-Mallah, 2016, Maternally administered cyclic glycine-proline increases insulin-like growth factor-1 bioavailability and novelty recognition in developing offspring, Endocrinology, 157, 3130, 10.1210/en.2016-1189 Guan, 2014, Cyclic glycine-proline regulates IGF-1 homeostasis by altering the binding of IGFBP-3 to IGF-1, Sci Rep, 4, 4388, 10.1038/srep04388 Guan, 2007, Peripheral administration of a novel diketopiperazine, NNZ 2591, prevents brain injury and improves somatosensory-motor function following hypoxia-ischemia in adult rats, Neuropharmacology, 53, 749, 10.1016/j.neuropharm.2007.08.010 Li, 2019, Cyclic glycine-proline administration normalizes high-fat diet-induced synaptophysin expression in obese rats, Neuropeptides, 76, 101935, 10.1016/j.npep.2019.05.006 Fan, 2018, Supplementation of blackcurrant anthocyanins increased cyclic glycine-proline in the cerebrospinal fluid of Parkinson patients, a potential treatment to improve insulin-like growth factor-1 function, Nutrients, 10, 714, 10.3390/nu10060714 Chen, 2009, 2, 5-diketopiperazines (cyclic dipeptides) in beef: identification, synthesis, and sensory evaluation, J Food Sci, 74, C100, 10.1111/j.1750-3841.2009.01062.x Ren, 2015, The insulin-like growth factor I system: physiological and pathophysiological implication in cardiovascular diseases associated with metabolic syndrome, Biochem Pharmacol, 93, 409, 10.1016/j.bcp.2014.12.006 Aguirre, 2016, Insulin-like growth factor-1 deficiency and metabolic syndrome, J Transl Med, 14, 3, 10.1186/s12967-015-0762-z Berryman, 2013, The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations, Nat Rev Endocrinol, 9, 346, 10.1038/nrendo.2013.64 Pires, 2013, The effects of hypertension on the cerebral circulation, Am J Physiol Heart Circ Physiol, 304, H1598, 10.1152/ajpheart.00490.2012 Sierra, 2011, Vascular mechanisms in the pathogenesis of stroke, Curr Hypertens Rep, 13, 200, 10.1007/s11906-011-0195-x Turin, 2016, Hypertension and lifetime risk of stroke, J Hypertens, 34, 116, 10.1097/HJH.0000000000000753 Haysom, 2017, Post-weaning high-fat diet results in growth cartilage lesions in young male rats, PLoS One, 12, 10.1371/journal.pone.0188411 Gray, 2013, Pre-weaning growth hormone treatment reverses hypertension and endothelial dysfunction in adult male offspring of mothers undernourished during pregnancy, PLoS One, 8, e53505, 10.1371/journal.pone.0053505 Perticone, 2008, Low-plasma insulin-like growth factor-I levels are associated with impaired endothelium-dependent vasodilatation in a cohort of untreated, hypertensive Caucasian subjects, J Clin Endocrinol Metab, 93, 2806, 10.1210/jc.2008-0646 Vickers, 2001, IGF-I treatment reduces hyperphagia, obesity, and hypertension in metabolic disorders induced by fetal programming, Endocrinology, 142, 3964, 10.1210/endo.142.9.8390 Lim, 2013, Ectopic fat and cardiometabolic and vascular risk, Int J Cardiol, 169, 166, 10.1016/j.ijcard.2013.08.077 Vickers, 2002, Adult growth hormone treatment reduces hypertension and obesity induced by an adverse prenatal environment, J Endocrinol, 175, 615, 10.1677/joe.0.1750615